Aspire Biopharma faces potential Nasdaq delisting after compliance shortfall
Smith & Nephew PLC (LSE:SN, NYSE:SNN) announced Thursday that it will release its trading report for the third quarter ended September 27, 2025, on Thursday, November 6, 2025. The report is scheduled to be published at 7:00 a.m. GMT (2:00 a.m. EST).
The company stated that a conference call for financial analysts will follow at 8:30 a.m. GMT (3:30 a.m. EST). Details for accessing the call will be made available on the Smith & Nephew website.
Smith & Nephew is a global medical technology company with operations in more than 100 countries. According to the press release, the company reported annual sales of $5.8 billion in 2024.
This information is based on a statement released by the company in a filing with the U.S. Securities and Exchange Commission.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.